CD300LG抗体CD300LG兔多抗抗体Triggerin
g receptor expressed on myeloid cells 4 antibody抗体CD300LG Antibody, FITC conjugated抗体- ￥880 - 1320
- CUSABIO
- CN
- CSB-PA751016LC01HU
- 2025年07月04日
- /
- Rabbit
- Human
企业认证
相关产品推荐更多 >
PON1抗体PON1兔多抗抗体Serum paraoxonase/arylesterase 1 antibody抗体PON1 Antibody, Biotin conjugated抗体
￥880
AOAH抗体AOAH兔多抗抗体AOAH_HUMAN antibody抗体AOAH Antibody, Biotin conjugated抗体
￥880
SLC9A3R2抗体SLC9A3R2一抗抗体Tyrosine kinase activator protein 1 antibody抗体SLC9A3R2 Antibody抗体
￥1100
SCRG1抗体SCRG1兔多抗抗体UNQ390/PRO725 antibody抗体SCRG1 Antibody, HRP conjugated抗体
￥880SMCP抗体SMCP兔多抗抗体Sperm mitochondrial-associated cysteine-rich protein antibody抗体SMCP Antibody, Biotin conjugated抗体
￥880
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
源叶生物 十万种现货试剂速发，品质稳、品类全，实验不再等！Takara 秋促来袭，提取+反转录+定量套装仅 1200 元abinScience 体内级抗体 全年锁价 低至 ￥1200阿拉丁 22万+ 科研级产品现货速发，品质严控、科研无忧- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Recombinant Human CMRF35-like molecule 9 protein (128-241AA)
- 亚型：
IgG
- 形态：
Liquid
- 保存条件：
Upon receipt, store at -20℃ or -80℃. Avoid repeated freeze.
- 克隆性：
Polyclonal
- 标记物：
FITC
- 适应物种：
Human
- 保质期：
6个月
- 抗原来源：
Homo sapiens (Human)
- 目录编号：
Q6UXG3
- 级别：
优
- 库存：
200
- 供应商：
武汉华美生物工程有限公司
- 宿主：
Rabbit
- 应用范围：
/
- 浓度：
>95%,Protein G purified
- 靶点：
CD300LG
- 抗体英文名：
CD300LG Antibody, FITC conjugated
- 抗体名：
Triggering receptor expressed on myeloid cells 4 antibody
- 规格：
100μg/50μg
| 规格： | 100μg | 产品价格： | ￥1320.0 |
|---|---|---|---|
| 规格： | 50μg | 产品价格： | ￥880.0 |
保存缓冲液
Preservative: 0.03% Proclin 300Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
功能
Receptor which may mediate L-selectin-dependent lymphocyte rollings. Binds SELL in a calcium dependent manner. Binds lymphocyte (By similarity).风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Uptake of Antigen-Antibody Complexes by Human Dendritic Cells
Fc receptors specific for IgG (FcγR) potentiate the immune response by facilitating the interaction between myeloid cells and antibody-coated targets (1 -3 ). Monocyte and neutrophil FcyR engagement can lead to the induction of lytic-type
Cytotoxic Tumor Targeting With scFv Antibody-Modified Liposomes
Specific targeting of liposome-formulated cytotoxic drugs or antigens to receptors expressed selectively on target cells represents an effective strategy for increasing the pharmacological efficacy of the delivered molecules
Chimerization of a Monoclonal Antibody for Treating Hodgkin's Lymphoma
Ber-H2 which recognizes the human CD30 molecule with high specificity and affinity (2 ). CD30, a member of the nerve growth factor (NGF) tumor necrosis factor receptor (TNFR) superfamily (3 ), is strongly expressed on the pathognomonic Hodgkin (H
技术资料暂无技术资料 索取技术资料
